J. Prince

L. Feuk, S. McCarthy, A. Brookes, 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

cDNA Sequencing of Nuclear NADH Dehydrogenase Subunit Genes in Complex I Deficient Myopathic Patients

A. Brookes, J. Prince, C. Angelini, 2000 .

Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction.

A. Bennet, J. Prince, U. Faire, 2003, Atherosclerosis.

The Cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer disease

K. Blennow, Hans Förstl, A. Kurz, 2006, Human mutation.

Mitochondrial activity in the mapping of functional brain changes in schizophrenia.

J. Prince, L. Oreland, 1998, Restorative neurology and neuroscience.

Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease.

K. Sleegers, A. Smith, P. Kehoe, 2005, American journal of epidemiology.

A cell culture model of cerebral ischemia as a convenient system to screen for neuroprotective drugs.

J. Prince, L. Oreland, J. Ekblom, 1998, Journal of neural transmission. Supplementum.

Association of TNF-alpha serum levels and TNFA promoter polymorphisms with risk of myocardial infarction.

U. de Faire, A. Bennet, J. Prince, 2006, Atherosclerosis.

Genome‐wide and gene‐based association implicates FRMD6 in alzheimer disease

E. Ingelsson, J. Lambert, P. Amouyel, 2012, Human mutation.

SNP association studies in Alzheimer's disease highlight problems for complex disease analysis.

L. Feuk, D. Clair, A. Brookes, 2001, Trends in genetics : TIG.

Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope.

U. de Faire, A. Bennet, J. Prince, 2004, Arthritis and rheumatism.

Identification of 167 polymorphisms in 88 genes from candidate neurodegeneration pathways.

A. Brookes, J. Prince, M. Jobs, 1999, Gene.

Towards compendia of negative genetic association studies: an example for Alzheimer disease

Kaj Blennow, Lars Feuk, L. Feuk, 2006, Human Genetics.

Retrospective Analysis of Coagulation Factor II Receptor (F2R) Sequence Variation and Coronary Heart Disease in Hypertensive Patients

U. de Faire, B. Gigante, J. Prince, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Associations of gene sequence variation and serum levels of C-reactive protein and interleukin-6 with Alzheimer's disease and dementia.

N. Pedersen, A. Bennet, C. Reynolds, 2011, Journal of Alzheimer's disease : JAD.

Pleiotropy in the Presence of Allelic Heterogeneity: Alternative Genetic Models fo rth eInfl uenc eo fAPOEo nSeru mLDL, CSF Amyloid- 42 ,an dDementia

K. Blennow, N. Pedersen, A. Bennet, 2010 .

Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease

L. Feuk, K. Blennow, A. Brookes, 2001, European Journal of Human Genetics.

Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease

M Mancuso, R Ferri, P. Bosco, 2012, Molecular Psychiatry.

Meta-analysis of the Association Between Variants in SORL 1 and Alzheimer Disease

J. Haines, M. Pericak-Vance, M. Owen, 2011 .

Genetic association of sequence variants near AGER/NOTCH4 and dementia.

K. Blennow, N. Pedersen, A. Alexeyenko, 2011, Journal of Alzheimer's disease : JAD.

A survey of ABCA1 sequence variation confirms association with dementia

K. Blennow, F. Wiklund, N. Pedersen, 2009, Human mutation.

Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE

B. Winblad, L. Fratiglioni, P. Kehoe, 2007, Neurobiology of Aging.

Quantitative trait loci in ABCA1 modify cerebrospinal fluid amyloid-β1-42 and plasma apolipoprotein levels

K. Blennow, A. Brookes, A. Bennet, 2006, Journal of Human Genetics.

Genetic association analysis: lessons from the study of Alzheimers disease.

A. Brookes, J. Prince, 2005, Mutation research.

Genetic variation in CTNNA3 encoding alpha-3 catenin and Alzheimer's disease

K. Blennow, A. Brookes, N. Bogdanovic, 2004, Neuroscience Letters.

Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to β‐amyloid metabolism

J. Palmgren, K. Blennow, N. Cairns, 2004, Human mutation.

Haplotypes extending across ACE are associated with Alzheimer's disease.

L. Feuk, K. Blennow, N. Cairns, 2003, Human molecular genetics.

Apolipoprotein-E dependent role for the FAS receptor in early onset Alzheimer's disease: finding of a positive association for a polymorphism in the TNFRSF6 gene

L. Feuk, G. Breen, A. Brookes, 2000, Human Genetics.

Transcriptome-Wide Assessment of Human Brain and Lymphocyte Senescence

A. Myers, P. Magnusson, J. Prince, 2008, PloS one.

Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease

Mario Cortina-Borja, Naomi Hammond, Panos Deloukas, 2013, Neurobiology of Aging.

A Genome‐Wide Assessment of Variability in Human Serum Metabolism

Y. Pawitan, H. Grönberg, Jianfeng Xu, 2013, Human mutation.

Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk.

Andrey Alexeyenko, Fredrik Wiklund, Bo Malmberg, 2010, Human molecular genetics.

Sequence variation in SORL1 and dementia risk in Swedes

K. Blennow, N. Pedersen, A. Bennet, 2010, neurogenetics.

Quantitative trait loci near the insulin-degrading enzyme (IDE) gene contribute to variation in plasma insulin levels.

A. Brookes, J. Prince, H. Gu, 2004, Diabetes.

Phenotype selection for detecting variable genes: a survey of cardiovascular quantitative traits and TNF locus polymorphism

A. Bennet, J. Prince, U. Faire, 2007, European Journal of Human Genetics.

Neuroleptic-induced mitochondrial enzyme alterations in the rat brain.

J. Prince, L. Oreland, J A Prince, 1997, The Journal of pharmacology and experimental therapeutics.

Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease

P. Bosco, Y. Kamatani, G. Spalletta, 2012, Molecular Psychiatry.

Staurosporine Differentiated Human SH-SY5Y Neuroblastoma Cultures Exhibit Transient Apoptosis and Trophic Factor Independence

J. Prince, L. Oreland, 1997, Brain Research Bulletin.

Evidence that the gene encoding insulin degrading enzyme influences human lifespan.

K. Blennow, P. Kehoe, N. Pedersen, 2008, Human molecular genetics.

A novel single nucleotide polymorphism of the neuropeptide Y (NPY) gene associated with alcohol dependence.

S. Mottagui-Tabar, C. Wahlestedt, D. Goldman, 2005, Alcoholism, clinical and experimental research.

Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia

K. Blennow, H. Hampel, F. Faltraco, 2003, Neuroscience Letters.

Variants of CYP46A1 may interact with age and APOE to influence CSF Aβ42 levels in Alzheimer’s disease

L. Feuk, K. Blennow, A. Brookes, 2004, Human Genetics.

Putamen Mitochondrial Energy Metabolism Is Highly Correlated to Emotional and Intellectual Impairment in Schizophrenics

K. Blennow, J. Prince, J. Harro, 2000, Neuropsychopharmacology.

A histochemical demonstration of altered cytochrome oxidase activity in the rat brain by neuroleptics

J. Prince, L. Oreland, M. Yassin, 1998, European Neuropsychopharmacology.

Normalization of cytochrome-c oxidase activity in the rat brain by neuroleptics after chronic treatment with PCP or methamphetamine

J. Prince, L. Oreland, M. Yassin, 1997, Neuropharmacology.

Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes.

S. Love, P. Kehoe, J. Prince, 2009, American journal of translational research.

Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.

L. Feuk, R. Petersen, L. Hersh, 2005, Human molecular genetics.

Serum Lipid Levels and Cognitive Change in Late Life

N. Pedersen, C. Reynolds, M. Gatz, 2010, Journal of the American Geriatrics Society.

Neither sequence variation in the IL-10 gene promoter nor presence of IL-10 protein in the cerebral cortex is associated with Alzheimer's disease

S. Love, P. Kehoe, J. Prince, 2006, Neuroscience Letters.

A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity.

K. Blennow, B. Lenhard, P. Kehoe, 2004, Human molecular genetics.

Common variants of ACE contribute to variable age-at-onset of Alzheimer’s disease

J. Palmgren, K. Blennow, N. Cairns, 2004, Human Genetics.

Genetic variation in MME in relation to neprilysin protein and enzyme activity, Aβ levels, and Alzheimer's disease risk.

P. Passmore, B. McGuinness, S. Todd, 2012, International journal of molecular epidemiology and genetics.

Genetic Association of CDC2 with Cerebrospinal Fluid Tau in Alzheimer’s Disease

K. Blennow, H. Hampel, L. Wahlund, 2005, Dementia and Geriatric Cognitive Disorders.

Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation.

L. Feuk, K. Blennow, A. Brookes, 2001, Genome research.

LRP-1 variation is not associated with risk of Alzheimer's disease.

P. Passmore, S. Love, P. Kehoe, 2010, International journal of molecular epidemiology and genetics.

Genetic Variants from Lipid-Related Pathways and Risk for Incident Myocardial Infarction

E. Ingelsson, A. Syvänen, C. Willenborg, 2013, PloS one.

APOE ε4 allele is associated with reduced cerebrospinal fluid levels of Aβ42

Henrik Zetterberg, Jonathan A. Prince, K. Blennow, 2004, Neurology.

APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42.

K. Blennow, J. Prince, H. Zetterberg, 2004, Neurology.

No association between the α2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression

K. Blennow, A. Brookes, L. Minthon, 2000, Journal of Neural Transmission.

Longitudinal Memory Performance During Normal Aging: Twin Association Models of APOE and Other Alzheimer Candidate Genes

L. Feuk, A. Brookes, N. Pedersen, 2006, Behavior genetics.

Association of TNF-α serum levels and TNFA promoter polymorphisms with risk of myocardial infarction

A. Bennet, J. Prince, U. Faire, 2006 .

Sequence variation in the proximity of IDE may impact age at onset of both Parkinson disease and Alzheimer disease

K. Blennow, A. Brookes, N. Pedersen, 2004, Neurogenetics.

Mitochondrial Function is Differentially Altered in the Basal Ganglia of Chronic Schizophrenics

K. Blennow, J. Prince, L. Oreland, 1999, Neuropsychopharmacology.

Methylenetetrahydrofolate Reductase Polymorphisms in Human Cataract

K. Blennow, J. Prince, H. Zetterberg, 2005 .

Genetic susceptibility sets for Alzheimer's disease identified from diverse candidate loci.

K. Blennow, E. Corder, J. Prince, 2008, Rejuvenation research.

An assessment of CETP sequence variation in relation to cognitive decline and dementia risk.

N. Pedersen, C. Reynolds, M. Gatz, 2011, International journal of molecular epidemiology and genetics.

Evaluation of neprilysin sequence variation in relation to CSF β-Amyloid levels and Alzheimer disease risk.

S. McCarthy, K. Blennow, J. Prince, 2010, International journal of molecular epidemiology and genetics.

Assigning precursor–product ion relationships in indiscriminant MS/MS data from non-targeted metabolite profiling studies

E. Ingelsson, C. Broeckling, J. Prince, 2013, Metabolomics.

Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk.

H. Grönberg, K. Blennow, F. Wiklund, 2010, Human molecular genetics.

Pleiotropy in the presence of allelic heterogeneity: alternative genetic models for the influence of APOE on serum LDL, CSF A β 42 , and Dementia

K. Blennow, A. Bennet, C. Reynolds, 2013 .

Genome‐wide and gene‐based association implicates FRMD6 in alzheimer disease

E. Ingelsson, J. Lambert, P. Amouyel, 2012, Human mutation.

Meta-analysis of the association between SORL1 variants and Alzheimer's disease

M. Pericak-Vance, M. Owen, W. Maier, 2010, Alzheimer's & Dementia.